Concepedia

Author

A Harłozińska

Wroclaw Medical University

Also Known As

A Harlozi0nska, A Harlozinska, A Harloziñska, A Harlozińska, A Harlozínska, A Harłozinska, A Harłoziñska, A Harłozińska, A. Harlozinska, A. Harloziñska

109

Publications

728

Citations

14

H-Index

31

Concepts

All Affiliations

Wroclaw Medical UniversityLublin Oncology CenterWroclaw University of Health and Sport SciencesPathological SocietyGroene Hart Ziekenhuis
AH

About

A Harłozińska is an author at Wroclaw Medical University specializing in pathology, medicine, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

315

2

Obstetrics

7

7

191

3

Immunology

5

5

166

4

Cell Biology

2

2

55

5

Gastroenterology

1

1

52

A Harłozińska

×

19

Publications

489

Citations

13

H-Index

YearCitations

Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin‐2 receptor α levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma

P Sedlaczek, Irena Frydecka, M Gabryś,

Cancer

2002

69

Prognostic Significance of CA 125 and TPS Levels after 3 Chemotherapy Courses in Ovarian Cancer Patients

A. van Dalen, Judith Favier, Alexander Burges,

Gynecologic Oncology

2000

56

Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.

B Slesak, A Harłozińska, Irena Porębska,

PubMed

1998

52

Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.

A Harłozińska, P Sedlaczek, J Kulpa,

PubMed

2004

42

Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients’ survival

Julia Dorn, Viktor Magdolen, Apostolos Gkazepis,

Annals of Oncology

2011

42

Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series

A Noworolska, A Harłozińska, Ronald Richter,

British Journal of Cancer

1985

35

Expression of p53 Protein and Ki-67 Reactivity in Ovarian Neoplasms:<i>Correlation With Histopathology</i>

A Harłozińska, Julia Bar, P Sedlaczek,

American Journal of Clinical Pathology

1996

23

Relationship between c-erbB-2 oncoprotein, epidermal growth factor receptor, and estrogen receptor expression in patients with ductal breast carcinoma. Association with tumor phenotypes.

A Harłozińska, Bar Jk, R Wenderski,

PubMed

1997

20

Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias.

Julia Bar, A Harłozińska, P Sedlaczek,

PubMed

2001

20

TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.

A Harłozińska, P Sedlaczek, A. van Dalen,

PubMed

1998

19

Page 1